Pulmonary Physical Therapy Techniques to Enhance Survival in Amyotrophic Lateral Sclerosis: A Systematic Review
Overview
Authors
Affiliations
Background And Purpose: Respiratory insufficiency is the primary cause of morbidity and mortality in individuals with amyotrophic lateral sclerosis (ALS). Although mechanical interventions are effective in prolonging survival through respiratory support, pulmonary physical therapy interventions are being investigated. The purpose of this systematic review was to examine the effectiveness of pulmonary physical therapy interventions across the progressive stages of ALS.
Methods: Six databases were searched for articles from inception to December 2014 investigating pulmonary physical therapy interventions in the ALS population. The search strategy followed Cochrane Collaboration guidelines with replication per database. Effect sizes (ES) were calculated for primary outcome measures: forced vital capacity (FVC) and peak cough expiratory flow (PCEF).
Results: Seven studies met inclusion criteria. Four studies used control groups whereas the remainder used repeated measures. With the exception of diaphragmatic breathing, pulmonary physical therapy interventions were effective in improving multiple respiratory outcome measures in this population. Inspiratory muscle training (IMT) was shown to prolong respiratory muscle strength with a strong effect size (ES = 1.48) for FVC. In addition, mean length of survival increased by 12 months. Lung volume recruitment training (LVRT) strongly enhanced immediate cough efficacy with improved FVC (ES = 1.02) and PCEF (ES = 1.82). Manually assisted cough (MAC) only improved PCEF by a small amount (ES = 0.15, bulbar ALS; ES = 0.16, classical ALS groups).
Discussion And Conclusions: Specific pulmonary physical therapy interventions (IMT, LVRT, and MAC) have effectiveness in improving respiratory outcome measures and increasing survival. These should be routinely incorporated into the comprehensive management of individuals with ALS. More rigorous methodological investigations should be performed to replicate these findings.Video abstract available with brief technique demonstration of IMT and LVRT (see Supplemental Digital Content 1, http://links.lww.com/JNPT/A136).
Magni E, Hochsprung A, Caceres-Matos R, Pabon-Carrasco M, Heredia-Camacho B, Solis-Marcos I Neurol Int. 2024; 16(6):1332-1342.
PMID: 39585060 PMC: 11587033. DOI: 10.3390/neurolint16060101.
The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment.
Wang L, Zhang L, Bai X, Qiang R, Zhang N, Hu Q Neurochem Res. 2024; 49(10):2653-2667.
PMID: 38864944 DOI: 10.1007/s11064-024-04194-w.
Li Z, Kang H Sci Rep. 2024; 14(1):11365.
PMID: 38762656 PMC: 11102473. DOI: 10.1038/s41598-024-62213-w.
Davoudi M, Boostani R, Manzari Z J Res Med Sci. 2024; 28:87.
PMID: 38510783 PMC: 10953734. DOI: 10.4103/jrms.jrms_300_22.
Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review.
de Campos P, Olsen W, Wymer J, Smith B Chron Respir Dis. 2023; 20:14799731231175915.
PMID: 37219417 PMC: 10214054. DOI: 10.1177/14799731231175915.